In Q2 fiscal 2026 (the quarter ended June 30, 2026), DexCom's largest region was United States, with $933.40 million or 71% of revenue, up 11.0% from a year earlier. Next: Non-US (29%).
By country, UNITED STATES brought in 71% and Non-US brought in 29% of revenue in Q2 fiscal 2026.
By sales channel, Through Intermediary brought in 84% and Directly to Consumer brought in 16% of revenue in Q2 fiscal 2026.
The fastest-growing region from a year earlier was Non-US (+18.6%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q1 fiscal 2018.

Fiscal quarters, from company filings
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $933.4M | $832.3M | $851.9M | $841.0M | 71% |
| Non-US | $375.0M | $359.6M | $357.4M | $316.1M | 29% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Country | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| UNITED STATES | $933.4M | $832.3M | $851.9M | $841.0M | 71% |
| Non-US | $375.0M | $359.6M | $357.4M | $316.1M | 29% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Sales channel | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Through Intermediary | $1.1B | $1.0B | $1.0B | $977.8M | 84% |
| Directly to Consumer | $206.0M | $181.6M | $183.3M | $179.3M | 16% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
United States: $933.40 million, or 71% of revenue, in Q2 fiscal 2026.
By region in Q2 fiscal 2026: United States (71%) and Non-US (29%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item |
|---|